Incyte CEO on New Drugs, Jakafi Applications

Feb. 20 (Bloomberg) -- Herve Hoppenot, chief executive officer of Incyte Corp., talks with Bloomberg’s Meg Tirrell about the company's Jakfi drug used to treat a bone marrow disorder called myelofibrosis, Incyte's drug pipeline and the outlook for growth. Shares of the cancer-drug maker have tripled in the last year. (Source: Bloomberg)

Five Things We Learned This Week (03/24)
46:09 - From the happiest people on earth to airlines cutting back on in-flight entertainment, here are five things we learned this week. (Source: Bloomberg)
  • Germany March Manufacturing PMI Rises to 58.3
  • Full Show: Surveillance (03/23)
  • Full Show: Bloomberg Daybreak: Australia (03/24)